These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21661178)

  • 1. [Alterations of mesangial cell and matrix].
    Kashihara N; Sato M; Komai N; Sasaki T
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():390-5. PubMed ID: 21661178
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
    Li Z; Zhang H; Dong X; Burczynski FJ; Choy P; Yang F; Liu H; Li P; Gong Y
    Biochem Cell Biol; 2010 Aug; 88(4):635-48. PubMed ID: 20651835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormality of type IV collagen metabolism in the development of diabetic nephropathy].
    Haneda M; Kikkawa R
    Nihon Rinsho; 1992 Dec; 50(12):3016-20. PubMed ID: 1491453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-1 stimulates production of mesangial cell matrix components.
    Schreiber BD; Hughes ML; Groggel GC
    Clin Nephrol; 1995 Jun; 43(6):368-74. PubMed ID: 7554520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NG2 proteoglycan increases mesangial cell proliferation and extracellular matrix production.
    Xiong J; Wang Y; Zhu Z; Liu J; Wang Y; Zhang C; Hammes HP; Lang F; Feng Y
    Biochem Biophys Res Commun; 2007 Oct; 361(4):960-7. PubMed ID: 17686464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of C-peptide on renal morphology in diabetic rats.
    Sun W; Gao X; Zhao X; Cui D; Xia Q
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
    Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasticity of mesangial cells: a basis for understanding pathological alterations.
    Herrera GA
    Ultrastruct Pathol; 2006; 30(6):471-9. PubMed ID: 17182440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesangial cell dysfunction as a pathogenesis of diabetic nephropathy.
    Haneda M; Koya D; Kikkawa R
    Contrib Nephrol; 2001; (134):16-29. PubMed ID: 11665284
    [No Abstract]   [Full Text] [Related]  

  • 10. The contribution of mesangial cell collagen synthesis to the pathogenesis of diabetic nephropathy.
    Kashgarian M; Oshima S; Takeuchi A; Throckmorton D; Rasmussen H
    Contrib Nephrol; 1994; 107():132-9. PubMed ID: 8004959
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy.
    Min D; Lyons JG; Bonner J; Twigg SM; Yue DK; McLennan SV
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1229-37. PubMed ID: 19741020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halofuginone prevents extracellular matrix deposition in diabetic nephropathy.
    Sato S; Kawamura H; Takemoto M; Maezawa Y; Fujimoto M; Shimoyama T; Koshizaka M; Tsurutani Y; Watanabe A; Ueda S; Halevi K; Saito Y; Yokote K
    Biochem Biophys Res Commun; 2009 Feb; 379(2):411-6. PubMed ID: 19114027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular mesangial fibrillary deposits in a patient with diabetes mellitus.
    Gonul II; Gough J; Jim K; Benediktsson H
    Int Urol Nephrol; 2006; 38(3-4):767-72. PubMed ID: 17211574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy.
    McLennan SV; Death AK; Fisher EJ; Williams PF; Yue DK; Turtle JR
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):123-35. PubMed ID: 10099846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic glomerulopathy in man and experimental animal models.
    Steffes MW; Mauer SM
    Int Rev Exp Pathol; 1984; 26():147-75. PubMed ID: 6400512
    [No Abstract]   [Full Text] [Related]  

  • 17. Mesangial pathology in glomerular disease: targets for therapeutic intervention.
    Scindia YM; Deshmukh US; Bagavant H
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1337-43. PubMed ID: 20828589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renal hemodynamic basis of diabetic nephropathy.
    O'Bryan GT; Hostetter TH
    Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mesangium: interactions between mesangial cells and extracellular matrix].
    Ivić M; Bogićević M; Stefanović V
    Srp Arh Celok Lek; 1994; 122(3-4):96-8. PubMed ID: 17972820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and extracellular matrix-cell interactions in kidney disease.
    Makino H; Sugiyama H; Kashihara N
    Kidney Int Suppl; 2000 Sep; 77():S67-75. PubMed ID: 10997693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.